Gene structure and organization of the human β‐secretase (BACE) promoter

No abstract is available for this paper.

• Publication year

  2004

• Venue

  The FASEB Journal

• Publication date

  2004-06-01

• Fields of study

  Biology, Chemistry

• Identifiers
  DOI 10.1096/fj.03-1378fje
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional characterization of the 5′ flanking region of the BACE gene: identification of a 91 bp fragment involved in basal level of BACE promoter expression

  2004cited by this paper
• Transcriptional Regulation of BACE1, the β-Amyloid Precursor Protein β-Secretase, by Sp1

  2004influential reference
• Role of cytokines in the gene expression of amyloid β–protein precursor: Identification of a 5'-UTR-Binding nuclear factor and its implications in Alzheimer's disease

  2003cited by this paper
• BACE1 and BACE2 in pathologic and normal human muscle.

  2003cited by this paper
• Multiple sequence alignment with the Clustal series of programs

  2003cited by this paper
• A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease.

  2003cited by this paper
• Database resources of the National Center for Biotechnology

  2003cited by this paper
• Cloning and expression of the rat BACE1 promoter

  2003influential reference
• Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences

  2002cited by this paper
• Regeneration and molecular characterization of intergeneric somatic hybrids between Citrus reticulata and Poncirus trifoliata

  2002cited by this paper
• Elevated expression of beta-site amyloid precursor protein cleaving enzyme 2 in brains of patients with Down syndrome.

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• A Portrait of Alzheimer Secretases--New Features and Familiar Faces

  2001cited by this paper
• Three novel alternatively spliced isoforms of the human beta-site amyloid precursor protein cleaving enzyme (BACE) and their effect on amyloid beta-peptide production.

  2001cited by this paper
• Presence of BACE1 and BACE2 in muscle fibres of patients with sporadic inclusion-body myositis.

  2001cited by this paper
• Human aspartic protease memapsin 2 cleaves the b-secretase site of b-amyloid precursor protein

  2000cited by this paper
• Amyloid precursor protein beta-secretase (BACE) mRNA expression in human neural cell lines following induction of neuronal differentiation and exposure to cytokines and growth factors.

  2000cited by this paper
• Expression Analysis of BACE2 in Brain and Peripheral Tissues*

  2000cited by this paper
• EMBOSS: the European Molecular Biology Open Software Suite.

  2000cited by this paper
• Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein.

  2000cited by this paper
• The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the Down critical region

  2000cited by this paper
• Caveolin-3 Upregulation Activates β-Secretase–Mediated Cleavage of the Amyloid Precursor Protein in Alzheimer’s Disease

  1999cited by this paper
• Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity

  1999cited by this paper
• Glycosylphosphatidylinositol-anchored Proteins Play an Important Role in the Biogenesis of the Alzheimer’s Amyloid β-Protein*

  1999cited by this paper
• Purification and cloning of amyloid precursor protein β-secretase from human brain

  1999cited by this paper
• Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

  1999cited by this paper
• Identification of a novel aspartic protease (Asp 2) as beta-secretase.

  1999cited by this paper
• BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT

  1999cited by this paper
• Caveolae, Plasma Membrane Microdomains for α-Secretase-mediated Processing of the Amyloid Precursor Protein*

  1998cited by this paper
• Functional identification of the promoter of the gene encoding the Rhesus monkey β-amyloid precursor protein

  1998cited by this paper
• Multiple sequence alignment with Clustal X.

  1998cited by this paper
• β-Secretase Processing of the β-Amyloid Precursor Protein in Transgenic Mice Is Efficient in Neurons but Inefficient in Astrocytes*

  1996cited by this paper
• An improved sequence assembly program.

  1996cited by this paper
• MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.

  1995cited by this paper
• Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1.

  1995cited by this paper
• Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

  1993cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

  1992cited by this paper
• Characterization of the 5'-end region and the first two exons of the beta-protein precursor gene.

  1989cited by this paper
• Characterization of the 5?-end region and the first two exons of the ?-protein precursor gene

  1989cited by this paper
• The promoter of Alzheimer's disease amyloid A4 precursor gene.

  1988cited by this paper
• Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells.

  1988cited by this paper
• ACE1 regulates expression of the Saccharomyces cerevisiae metallothionein gene

  1988cited by this paper

• Role of the PKA–PGC1α–BACE1 Signaling Pathway in Aluminum-Induced Neurotoxicity in PC12 Cells

  2025cites this paper
• Cognitive impairment in Sjogren’s syndrome: Interplay between BACE1 activity, inflammatory blood biomarkers and neurocognitive testing

  2025cites this paper
• BACE1 as an early biomarker and its relevance to risk factors for Alzheimer's disease.

  2025cites this paper
• Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models

  2025cites this paper
• Comprehensive medicinal chemistry survey highlights a portfolio of lead molecules for Alzheimer’s disease therapy

  2025cites this paper
• PINK1-dependent NFKB signaling contributes to amyloid pathology in Alzheimer disease

  2025cites this paper
• Lupeol protect against LPS-induced neuroinflammation and amyloid beta in adult mouse hippocampus

  2024cites this paper
• Exploring complexities of Alzheimer's disease: New insights into molecular and cellular mechanisms of neurodegeneration and targeted therapeutic interventions.

  2024cites this paper
• Increased Plasma β‐Secretase 1 Activity Correlates With Neurodegeneration in Cerebral Small Vessel Disease

  2024cites this paper
• Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis

  2024cites this paper
• The pathomimetic oAβ25-35 model of Alzheimer's disease: Potential for screening of new therapeutic agents.

  2023cites this paper
• BACE1: More than just a β‐secretase

  2022cites this paper
• Alternative Pharmacological Strategies for the Treatment of Alzheimer’s Disease: Focus on Neuromodulator Function

  2022cites this paper
• Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions

  2022cites this paper
• Cleavage of Kv2.1 by BACE1 decreases potassium current and reduces neuronal apoptosis.

  2022cites this paper
• Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease

  2022cites this paper
• Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model

  2021cites this paper
• Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties.

  2021cites this paper
• Disarranged neuroplastin environment upon aging and chronic stress recovery in female Sprague Dawley rats

  2021cites this paper
• Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders

  2021cites this paper
• Glucocorticoid receptors signaling impairment potentiates amyloid‐β oligomers‐induced pathology in an acute model of Alzheimer’s disease

  2020cites this paper
• Characterization and Neuroprotection Potential of Seleno-Polymannuronate

  2020cites this paper
• Amyloid Beta-Peptide Increases BACE1 Translation through the Phosphorylation of the Eukaryotic Initiation Factor-2α

  2020cites this paper
• Inhibitory Effect of Hexahydrocurcumin on Memory Impairment and Amyloidogenesis in Dexamethasone-Treated Mice

  2020cites this paper
• Navigating Alzheimer's Disease via Chronic Stress: the Role of Glucucocorticoids.

  2020cites this paper
• Inhibitory Effect of Hexahydrocurcumin on Memory Impairment and Amyloidogenesis in Dexamethasone-Treated Mice

  2020cites this paper
• Correlation of Serum BACE1 With Emergence Delirium in Postoperative Patients: A Preliminary Study

  2020cites this paper
• Multiple BACE1 inhibitors abnormally increase the BACE1 protein level in neurons by prolonging its half‐life

  2019cites this paper
• Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments

  2019cites this paper
• NF-κB as a Key Mediator of Brain Inflammation in Alzheimer's Disease.

  2019cites this paper
• Oxidative Stress in Alzheimer’s Disease: Molecular Hallmarks of Underlying Vulnerability

  2019cites this paper
• Icariside II inhibits lipopolysaccharide-induced inflammation and amyloid production in rat astrocytes by regulating IKK/IκB/NF-κB/BACE1 signaling pathway

  2019cites this paper
• Bee Venom Soluble Phospholipase A2 Exerts Neuroprotective Effects in a Lipopolysaccharide-Induced Mouse Model of Alzheimer’s Disease via Inhibition of Nuclear Factor-Kappa B

  2019cites this paper
• Treatment of Neurodegenerative Diseases with Bioactive Components of Tripterygium wilfordii.

  2019cites this paper
• Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis

  2019cites this paper
• Estrogen deficiency exacerbates Aβ-induced memory impairment through enhancement of neuroinflammation, amyloidogenesis and NF-ĸB activation in ovariectomized mice.

  2018cites this paper
• Vulnerability and resilience to Alzheimer’s disease: early life conditions modulate neuropathology and determine cognitive reserve

  2018cites this paper
• Could Alzheimer’s Disease Originate in the Periphery and If So How So?

  2018cites this paper
• Exercise decreases BACE and APP levels in the hippocampus of a rat model of Alzheimer's disease

  2018cites this paper
• Targeting Glucocorticoid Receptors: A New Avenue for Alzheimer’s Disease Therapy

  2018cites this paper
• Piperlongumine Improves Lipopolysaccharide-Induced Amyloidogenesis by Suppressing NF-KappaB Pathway

  2018cites this paper
• Preventing synaptic deficits in Alzheimer’s disease by inhibiting tumor necrosis factor alpha signaling

  2018cites this paper
• Targeting glucocorticoid receptors prevents the effects of early life stress on amyloid pathology and cognitive performance in APP/PS1 mice

  2018cites this paper
• Inflammation as a central mechanism in Alzheimer's disease

  2018cites this paper
• Central Role of Glucocorticoid Receptors in Alzheimer’s Disease and Depression

  2018cites this paper
• Cross-Sectional and Longitudinal Effects of CREB1 Genotypes on Individual Differences in Memory and Executive Function: Findings from the BLSA

  2017cites this paper
• The role of astrocytes in amyloid production and Alzheimer's disease

  2017cites this paper
• (E)-2-Methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) Phenol Ameliorates LPS-Mediated Memory Impairment by Inhibition of STAT3 Pathway

  2017cites this paper
• α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP

  2017cites this paper
• Membrane-Associated Effects of Glucocorticoid on BACE1 Upregulation and Aβ Generation: Involvement of Lipid Raft-Mediated CREB Activation

  2017cites this paper
• PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer’s disease

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Positive and negative early life experiences differentially modulate long term survival and amyloid protein levels in a mouse model of Alzheimer ’ s disease

  2016cites this paper
• The Synergistic Roles of the Chronic Prenatal and Offspring Stress Exposures in Impairing Offspring Learning and Memory

  2016cites this paper
• Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway

  2016cites this paper
• Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms

  2016cites this paper
• Positive and negative early life experiences differentially modulate long term survival and amyloid protein levels in a mouse model of Alzheimer's disease

  2016cites this paper
• Novel Nuclear Factor-KappaB Targeting Peptide Suppresses β-Amyloid Induced Inflammatory and Apoptotic Responses in Neuronal Cells

  2016cites this paper
• New selective glucocorticoid receptor modulators reverse amyloid-β peptide-induced hippocampus toxicity.

  2016cites this paper
• Effects of chronic variable stress on cognition and Bace1 expression among wild-type mice

  2016cites this paper
• Alpha-synuclein expression influences the processing of the amyloid precursor protein

  2016cites this paper
• Neuroinflammatory and Amyloidogenic Activities of IL-32β in Alzheimer’s Disease

  2015cites this paper
• Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer’s disease and multiple sclerosis

  2015cites this paper
• Chronic Anatabine Treatment Reduces Alzheimer’s Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD

  2015cites this paper
• Inhibitory effect of ent-Sauchinone on amyloidogenesis via inhibition of STAT3-mediated NF-κB activation in cultured astrocytes and microglial BV-2 cells

  2014cites this paper
• High activities of BACE1 in brains with mild cognitive impairment.

  2014cites this paper
• Evidence of a Novel Mechanism for Partial γ-Secretase Inhibition Induced Paradoxical Increase in Secreted Amyloid β Protein

  2014cites this paper
• Two novel DNA motifs are essential for BACE1 gene transcription

  2014cites this paper
• Amelioration of Cognitive Dysfunction in APP/PS1 Double Transgenic Mice by Long-Term Treatment of 4-O-Methylhonokiol

  2014cites this paper
• Genetic Studies in Human Prion Diseases

  2014cites this paper
• Envisioning PACAP-Based Therapy for Alzheimer's Disease.

  2014cites this paper
• Knock-In of Human BACE1 Cleaves Murine APP and Reiterates Alzheimer-like Phenotypes

  2014cites this paper
• Multiple Mechanisms of Iron-Induced Amyloid Beta-Peptide Accumulation in SHSY5Y Cells: Protective Action of Negletein

  2014cites this paper
• Surgical menopause enhances hippocampal amyloidogenesis following global cerebral ischemia

  2014cites this paper
• Genetic deletion of TNFRII gene enhances the Alzheimer-like pathology in an APP transgenic mouse model via reduction of phosphorylated IκBα.

  2014cites this paper
• Inhibitory effect of a 2,4-bis(4-hydroxyphenyl)-2-butenal diacetate on neuro-inflammatory reactions via inhibition of STAT1 and STAT3 activation in cultured astrocytes and microglial BV-2 cells.

  2014cites this paper
• Novel lipid signaling pathways in Alzheimer's disease pathogenesis.

  2014cites this paper
• Lessons from a BACE1 inhibitor trial: Off‐site but not off base

  2014cites this paper
• Flavonoids as regulators of amyloid precursor protein processing

  2014cites this paper
• β-Secretase: its biology as a therapeutic target in diseases.

  2013cites this paper
• BACE1 levels by APOE genotype in non-demented and Alzheimer's post-mortem brains.

  2013cites this paper
• Mechanisms of palmitate induced amyloidogenesis in Alzheimer's disease mediated by astrocytes

  2013cites this paper
• Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Aβ and pTau in a mouse model of Alzheimer's disease.

  2013cites this paper
• Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology

  2013cites this paper
• P3–076: Palmitate induces transcriptional regulation of BACE1 and presenilin by STAT3 in neurons mediated by astrocytes

  2013cites this paper
• Physical evidence supporting a ribosomal shunting mechanism of translation initiation for BACE1 mRNA

  2013cites this paper
• Identification of potent inhibitors for β-secretase through structure based virtual screening and molecular dynamics simulations

  2013cites this paper
• Tenascin-C deficiency ameliorates Alzheimer's disease-related pathology in mice.

  2013cites this paper
• Oxidative Stress and the Pathogenesis of Alzheimer's Disease

  2013cites this paper
• MicroRNA-339-5p Down-regulates Protein Expression of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 (BACE1) in Human Primary Brain Cultures and Is Reduced in Brain Tissue Specimens of Alzheimer Disease Subjects*

  2013cites this paper
• Anti-inflammatory and anti-amyloidogenic effects of a small molecule, 2,4-bis(p-hydroxyphenyl)-2-butenal in Tg2576 Alzheimer’s disease mice model

  2013cites this paper
• Elevation of BACE in an Aβ rat model of Alzheimer's disease: exacerbation by chronic stress and prevention by nicotine.

  2012cites this paper
• BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer’s disease

  2012cites this paper
• Amyloid-β Production: Major Link Between Oxidative Stress and BACE1

  2012cites this paper
• BACE2 expression increases in human neurodegenerative disease.

  2012cites this paper
• Structural and functional characterization of H2 haplotype MAPT promoter: unique neurospecific domains and a hypoxia-inducible element would enhance rationally targeted tauopathy research for Alzheimer's disease.

  2012cites this paper
• Obovatol improves cognitive functions in animal models for Alzheimer’s disease

  2012cites this paper
• BACE1 in Alzheimer's disease.

  2012cites this paper
• Regulation of β‐site APP‐cleaving enzyme 1 gene expression and its role in Alzheimer’s Disease

  2012cites this paper
• Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-κB signaling pathway.

  2012cites this paper
• β‐Amyloid 1‐42 induces physiological transcriptional regulation of BACE1

  2012cites this paper